Skip to content

Anatomic Endoscopic Prostate Enucleation and BICEP Classification

Multicentric Prospective Evaluation of Bladder Injuries During Morcellation Using BICEP (Bladder Injury Classification During Endoscopic Procedures)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06469125
Acronym
BICEP
Enrollment
250
Registered
2024-06-21
Start date
2025-10-08
Completion date
2025-11-14
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Injury, Prostate Hyperplasia

Keywords

BICEP classification, Anatomic Endoscopic Enucleation of Prostate, Bladder Injury, HoLEP, BiLEP, ThuFLEP

Brief summary

The Bladder Injury Classification System for Endoscopic Procedure (BICEP) is designed to provide a systematic framework for categorizing bladder injuries that occur during endoscopic procedures. By standardizing the classification of these injuries, BICEP promotes a more consistent approach to diagnosis, management, and prevention across different urologic interventions. This study aims to validate and implement the BICEP system during morcellation. This study will: Validate BICEP by using real-life clinical scenarios to ensure its applicability and effectiveness. Assess the incidence and types of bladder injuries during morcellation, using the BICEP categorization to standardize injury reporting and enhance treatment protocols.

Detailed description

Insufficient knowledge exists about bladder injuries during morcellation, as the existing literature primarily consists of isolated case reports. The Bladder Injury Classification System for Endoscopic Procedures (BICEP) aims to standardize the reporting and management of bladder injuries during endoscopic surgeries. This study proposes an external validation of the BICEP system through an international, multicenter, prospective observational study. The objectives of this study are fourfold: Validate the newly developed BICEP classification system with real-life clinical scenarios to ensure its applicability and effectiveness. Evaluate the incidence and types of bladder injuries during morcellation using the BICEP framework to standardize injury reporting and enhance treatment protocols. Assess the robustness of BICEP across different departments. Facilitate the adoption of BICEP as a global standard for classifying bladder injuries in endoscopic surgery. Through this study, the validity of BICEP will be confirmed and the bladder injuries occurring during morcellation after AEEP will be examined.

Interventions

PROCEDUREEndoscopic Prostate Interventions for Anatomic Enucleation

The intervention in this study involves performing anatomic endoscopic enucleation of the prostate (AEEP) using different energy sources. Following the enucleation, the resected prostate tissue will be morcellated within the bladder using various morcellators to remove the enlarged prostate tissue minimally invasively. The process will also involve evaluating and categorizing any resulting bladder injuries using the BICEP classification system.

Sponsors

Danube University Krems
CollaboratorOTHER
University General Hospital of Heraklion
CollaboratorOTHER
Paracelsus Medical University
CollaboratorOTHER
University of Turin, Italy
CollaboratorOTHER
Menoufia University
CollaboratorOTHER
Acibadem Ankara Hospital
CollaboratorOTHER
Universitätsmedizin Mannheim
CollaboratorOTHER
Martini-Klinik am UKE GmbH
CollaboratorOTHER
Asklepios Kliniken Hamburg GmbH
CollaboratorOTHER
Istanbul Medipol University Hospital
CollaboratorOTHER
Saint Petersburg State University, Russia
CollaboratorOTHER
HM Sanchinarro University Hospital
CollaboratorOTHER
Alexandria University
CollaboratorOTHER
Spital Thurgau AG
CollaboratorOTHER
Medical University of Graz
CollaboratorOTHER
King's College Hospital NHS Trust
CollaboratorOTHER
Sheikh Khalifa Medical City
CollaboratorOTHER
Necmettin Erbakan University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients aged ≥40 * ASA (American Society of Anesthesiologists) score ≤4 * Patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) surgery.

Exclusion criteria

* Patients with neurological disorders that may affect bladder function, such as cerebrovascular stroke or Parkinson's disease. * Patients with active urinary tract infection. * Patients diagnosed with bladder cancer within the last 2 years. * Patients with prostate cancer. * Patients who have undergone previous prostate surgery.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants with Successful Validation of the Bladder Injury Classification System for Endoscopic Procedure Classification System for Bladder Injuries Occurring During Morcellation in AEEP OperationsUp to 24 weeksApproximately 250 participants will be evaluated using a scoring system ranging from 0 to 4 to assess the severity of the injury. A score of 0 indicates no injury, while a score of 4 indicates extensive avulsion of part of the bladder. In this system, the severity of the injury increases as the score increases.
The impact of different energy sources and morcellation devices on bladder injuryUp to 24 weeksThe severity of the injury will be assessed using a scoring system ranging from 0 to 4. A score of 0 indicates no injury, while a score of 4 indicates the highest degree of avulsion of part of the bladder. In this system, the severity of the injury increases as the score increases.

Secondary

MeasureTime frameDescription
Postoperative Qmax Increase Following Morcellation in AEEP Operations1 month post surgeryAssessed by maximum flow rate (Q-max) measured using uroflowmetry by ml/sec, better outcome above 15ml/sec
Postoperative Improvement in International Prostate Symptom Score (IPSS)1 month post surgeryThe IPSS form will be filled out for calculation. Scores of 0-7 indicate mild symptoms, 8-19 indicate moderate symptoms, and 20-35 indicate severe symptoms.
Duration of catheterizationUp to 10 weeksThe duration of catheterization post-operation will be calculated in days.
Length of hospital stayUp to 6 weeksThe duration of hospital stay post-operation will be calculated in days.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026